A subset of schizophrenia with an inadequate response in target symptoms following treatment with two or more ANTIPSYCHOTICS.
Phase 4 trials (5)
Phase 3 trials (2)
Phase 2 trials (3)
Phase 1 trials (2)
Other trials (4)